Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association

Jie Oh Lee, Haijuan Yang, Maria Magdalena Georgescu, Antonio Di Cristofano, Tomohiko Maehama, Yigong Shi, Jack E. Dixon, Pier Pandolfi, Nikola P. Pavletich

Research output: Contribution to journalArticle

777 Scopus citations

Abstract

The PTEN tumor suppressor is mutated in diverse human cancers and in hereditary cancer predisposition syndromes. PTEN is a phosphatase that can act on both polypeptide and phosphoinositide substrates in vitro. The PTEN structure reveals a phosphatase domain that is similar to protein phosphatases but has an enlarged active site important for the accommodation of the phosphoinositide substrate. The structure also reveals that PTEN has a C2 domain. The PTEN C2 domain binds phospholipid membranes in vitro, and mutation of basic residues that could mediate this reduces PTEN's membrane affinity and its ability to suppress the growth of glioblastoma tumor cells. The phosphatase and C2 domains associate across an extensive interface, suggesting that the C2 domain may serve to productively position the catalytic domain on the membrane.

Original languageEnglish (US)
Pages (from-to)323-334
Number of pages12
JournalCell
Volume99
Issue number3
DOIs
StatePublished - Oct 29 1999

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association'. Together they form a unique fingerprint.

  • Cite this

    Lee, J. O., Yang, H., Georgescu, M. M., Cristofano, A. D., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999). Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell, 99(3), 323-334. https://doi.org/10.1016/S0092-8674(00)81663-3